On March 13, 2018 Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient’s immune system against cancer,.reported that it will present at the BIO-Europe Spring Conference in Amsterdam (Press release, Heat Biologics, MAR 13, 2018, View Source [SID1234524969]). Jeff Hutchins, Ph.D., and Chief Scientific and Operating Officer for Heat, will present at 9:30 a.m. CET/3 p.m. ET, on Wednesday, March 14, 2018. Dr. Hutchins will also be available to participate in one-on-one meetings with biotech/pharmaceutical executives registered to attend the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BIO-Europe brings together some of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, partnering meetings, strategic panels discussions and more